The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
Open accessAbstract
INTRODUCTION: Resveratrol is a polyphenol found in grapes and red wines. Interest in this polyphenol has increased due to its pharmacological cardio- and neuroprotective, chemopreventive, and antiaging effects, among others. Nevertheless, its pharmacokinetic properties are less favorable, since the compound has poor bioavailability, low water solubility, and is chemically unstable. To overcome these problems, we developed two novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance resveratrol's oral bioavailability for further use in medicines, supplements, and nutraceuticals. METHODS AND MATERIALS: Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) loaded with resveratrol were successfully produced by a modified hot homogenization technique. These were completely characterized to evaluate the quality of the developed resveratrol-loaded nanoparticles. RESULTS: Cryo-scanning electron microscopy morphology studies showed spherical and uniform nanoparticles with a smooth surface. An average resveratrol entrapment efficiency of ~70% was obtained for both SLNs and NLCs. Dynamic light scattering measurements gave a Z-average of 150-250 nm, polydispersity index of ~0.2, and a highly negative zeta potential of around -30 mV with no statistically significant differences in the presence of resveratrol. These characteristics remained unchanged for at least 2 months, suggesting good stability. Differential scanning calorimetry studies confirmed the solid state of the SLNs and NLCs at both room and body temperatures. The NLCs had a less ordered crystalline structure conferred by the inclusion of the liquid lipid, since they had lower values for phase transition temperature, melting enthalpy, and the recrystallization index. The presence of resveratrol induced a disorder in the crystal structure of the nanoparticles, suggesting a favoring of its entrapment. The in vitro release studies on conditions of storage showed a negligible resveratrol release over several hours for both nanosystems and the in vitro simulation of gastrointestinal transit showed that the resveratrol remained mostly associated with the lipid nanoparticles after their incubation in digestive fluids. CONCLUSION: Both nanodelivery systems can be considered suitable carriers for oral administration, conferring protection to the incorporated resveratrol and allowing a controlled release after uptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 874
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Bioavailability oftrans-resveratrol from red wine in humans
Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C., Caporaso, N., Vescovi, P. P., Fogliano, V., & Marchelli, R. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500002 · Cited by 313
R. Neves, A., Lucio, M., L.C. Lima, J., & Reis, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945085 · Cited by 313
Self-citationThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrol
Teskač, K., & Kristl, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.011 · Cited by 288
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Vivek, K., Reddy, H., & Murthy, R. S. R. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804083 · Cited by 234
Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells
Caddeo, C., Teskač, K., Sinico, C., & Kristl, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.024 · Cited by 218
Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles
Siekmann, B., & Westesen, K. (1994) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(94)80063-4 · Cited by 217
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC
Teeranachaideekul, V., Boonme, P., Souto, E. B., Müller, R. H., & Junyaprasert, V. B. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.011 · Cited by 215
Westesen, K., Siekmann, B., & Koch, M. H. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90177-h · Cited by 206
Stabilization and encapsulation of photosensitive resveratrol within yeast cell
Shi, G., Rao, L., Yu, H., Xiang, H., Yang, H., & Ji, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.044 · Cited by 195
Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress
Lu, X., Ji, C., Xu, H., Li, X., Ding, H., Ye, M., Zhu, Z., Ding, D., Jiang, X., Ding, X., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.021 · Cited by 190
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Dubes, A., Parrot-Lopez, H., Abdelwahed, W., Degobert, G., Fessi, H., Shahgaldian, P., & Coleman, A. W. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00020-1 · Cited by 174
Shao, J., Li, X., Lu, X., Jiang, C., Hu, Y., Li, Q., You, Y., & Fu, Z. (2009) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.03.010 · Cited by 172
β‐Carotene‐Loaded Nanostructured Lipid Carriers
Hentschel, A., Gramdorf, S., Müller, R. H., & Kurz, T. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2007.00641.x · Cited by 167
Saupe, A., Wissing, S. A., Lenk, A., Schmidt, C., & Müller, R. H. (2005) · PubMed · Cited by 144
Das, S., & Ng, K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21880 · Cited by 91
KOMATSU, H., KITAJIMA, A., & Okada, S. (1995) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.43.1412 · Cited by 74
Rieux, A. D., Fiévez, V., Momtaz, M., Detrembleur, C., Alonso, M. J., van Gelder, J., Cauvin, A. J., Schneider, Y., & Véronique Préat, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.023 · Cited by 58
Pegi, A., Kristl, J., Pečar, S., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10277 · Cited by 44
Cited by
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Wang, S., Su, R., Nie, S., Sun, M., Zhang, J., Wu, D., & Moustaid-Moussa, N. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.002 · Cited by 531
Elmowafy, M., & Al-Sanea, M. M. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.07.015 · Cited by 382
Metadata
- Authors
- Reis, S., Neves, Lúcio, Martins, & Lima
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-01
- Volume
- 8
- Pages
- 177
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2042898475
- Cited by
- 368
- References
- 31
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.